Boston An independent LDT provider
OBS:Immunovia har upphört med kommersialiseringen av IMMray PanCan-d-testet. Mer information finns här: https://rb.gy/zmwfz

Poster: Commercial Test Model Study – A multicenter survey

februari 1, 2021

Payam Delfani, Anders Carlsson, Thomas King, Randall Brand, Alexander Ney, Stephen P Pereira, A. James Moser, Genesis Perez-Melara, Corinne DeCicco, Alfredo Carrato, María E. Castillo-Sánchez, Julie Earl, Linda Dexlin Mellby

Acknowledgements: Immunovia would like to acknowledge, Diane M. Simone, MD, Director of the Pancreatic Cancer Center at NYU Langone’s Perlmutter Cancer Center, New York City, USA, Amy Lucas MD, Mount Sinai School of Medicine, New York City, USA and Växjö Central Hospital, Department of Transfusion Medicine, Sweden, for providing samples for the Commercial Test Model Study

The IMMray™ PanCan-d Commercial Test Model Study avslutades under 2019.

Klicka här för att läsa postern i sin helhet (pdf), Feb 2021